alexa Methods Of Treatment Of Neuro-ophthalmological Disorders Of The Organ Of Vision With Donepezil Hydrochloride Or Aricept?
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

4th International Conference on Clinical & Experimental Ophthalmology
July 14-16, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

Victor V.Sevastyanov
Posters: J Clin Exp Ophthalmol
DOI: 10.4172/2155-9570.S1.018
Abstract
This method id used for treating neuro-ophthalmological disorders of the organ of vision caused by optic nerve atrophy; partial optic nerve atrophy; Leber's optic atrophy; optic neuritis; toxic optic neuropathies; traumatic optic neuropathies; pigmentary degeneration of retina; cortical blindness by administering a therapeutically effective amount of Donepezil hydrochloride or ARICEPT? according to a specifically designed technology, which has been used by the author for 15 years. A method of treating of the diseases of the organ of vision: neuropathy of various genesis, optic atrophy, pigmentary degeneration of retina in adults consisting in administering donepezil hydrochloride (ARICEPT?) in the dosage 2.5-5 mg, one or two times a day in 3-15 courses of treatment 20-25 days each. The treatment according to this method substantially improves visual functions. A method of treating of the diseases of the organ of vision: optic nerve atrophy in children at the age of 5 and over consisting in administering donepezil hydrochloride (ARICEPT?) in the dosage 0.625-1.5 mg, one or two times a day in 3-15 courses of treatment 20-25 days each. The treatment substantially improves visual functions.
Biography
This method id used for treating neuro-ophthalmological disorders of the organ of vision caused by optic nerve atrophy; partial optic nerve atrophy; Leber's optic atrophy; optic neuritis; toxic optic neuropathies; traumatic optic neuropathies; pigmentary degeneration of retina; cortical blindness by administering a therapeutically effective amount of Donepezil hydrochloride or ARICEPT? according to a specifically designed technology, which has been used by the author for 15 years. A method of treating of the diseases of the organ of vision: neuropathy of various genesis, optic atrophy, pigmentary degeneration of retina in adults consisting in administering donepezil hydrochloride (ARICEPT?) in the dosage 2.5-5 mg, one or two times a day in 3-15 courses of treatment 20-25 days each. The treatment according to this method substantially improves visual functions. A method of treating of the diseases of the organ of vision: optic nerve atrophy in children at the age of 5 and over consisting in administering donepezil hydrochloride (ARICEPT?) in the dosage 0.625-1.5 mg, one or two times a day in 3-15 courses of treatment 20-25 days each. The treatment substantially improves visual functions.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords